Skip to main content
Clinical Trials/NCT07341542
NCT07341542
Not yet recruiting
Not Applicable

Assessment of Surgical Margins in Breast Cancer Patients Using the Histolog Scanner: A Pilot Prospective Study in the Czech Republic

Silesian Hospital in Opava1 site in 1 country20 target enrollmentStarted: January 20, 2026Last updated:

Overview

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Silesian Hospital in Opava
Enrollment
20
Locations
1
Primary Endpoint
Reduction of reoperation rate (%)

Overview

Brief Summary

A prospective clinical study investigating the use of the Histolog Scanner for intraoperative assessment of surgical margins in patients undergoing breast-conserving surgery for histologically confirmed breast cancer. The Histolog Scanner operates on the principle of confocal microscopy and enables non-destructive evaluation of specimen margins. The specimen will subsequently be sent for standard histopathological assessment; therefore, the use of this method does not pose any risk to the patient, as the diagnostic and therapeutic pathway for breast cancer will not be altered.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • breast cancer confirmed by core-cut biopsy
  • indication for breast-conserving surgery by a multidisciplinary team
  • surgical therapy in Silesian Hospital in Opava during the study period

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Reduction of reoperation rate (%)

Time Frame: 4 months

Intraoperative assessment of the surgical specimen using the Histolog Scanner in breast cancer patients undergoing breast-conserving surgery reduces the likelihood of reoperation for an R1 resection, i.e., tumor involvement at the surgical margin.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Silesian Hospital in Opava
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jan Žatecký

Jan Žatecký, MD, PhD

Silesian Hospital in Opava

Study Sites (1)

Loading locations...

Similar Trials